178 related articles for article (PubMed ID: 9165227)
1. High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study.
Frénais R; Ouguerram K; Maugeais C; Mahot P; Maugère P; Krempf M; Magot T
Diabetologia; 1997 May; 40(5):578-83. PubMed ID: 9165227
[TBL] [Abstract][Full Text] [Related]
2. In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus.
Frénais R; Nazih H; Ouguerram K; Maugeais C; Zaïr Y; Bard JM; Charbonnel B; Magot T; Krempf M
J Clin Endocrinol Metab; 2001 May; 86(5):1962-7. PubMed ID: 11344192
[TBL] [Abstract][Full Text] [Related]
3. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
[TBL] [Abstract][Full Text] [Related]
4. Chronic hypothyroidism induces abnormal structure of high-density lipoproteins and impaired kinetics of apolipoprotein A-I in the rat.
Huesca-Gómez C; Franco M; Luc G; Montaño LF; Massó F; Posadas-Romero C; Pérez-Méndez O
Metabolism; 2002 Apr; 51(4):443-50. PubMed ID: 11912551
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
Saku K; Gartside PS; Hynd BA; Mendoza SG; Kashyap ML
Metabolism; 1985 Aug; 34(8):754-64. PubMed ID: 3927110
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease.
Bakogianni MC; Kalofoutis CA; Skenderi KI; Kalofoutis AT
J Diabetes Complications; 2001; 15(5):265-9. PubMed ID: 11522502
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A-IV levels and phenotype distribution in NIDDM.
Vergès BL; Vaillant G; Goux A; Lagrost L; Brun JM; Gambert P
Diabetes Care; 1994 Aug; 17(8):810-7. PubMed ID: 7956623
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein AI and HDL are reduced in stable cirrhotic patients with adrenal insufficiency: a possible role in glucocorticoid deficiency.
Spadaro L; Noto D; Privitera G; Tomaselli T; Fede G; Scicali R; Piro S; Fayer F; Altieri I; Averna M; Purrello F
Scand J Gastroenterol; 2015 Mar; 50(3):347-54. PubMed ID: 25592451
[TBL] [Abstract][Full Text] [Related]
9. HDL subparticles and coronary artery disease in NIDDM.
O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Kottke BA
Atherosclerosis; 1996 Apr; 121(2):285-91. PubMed ID: 9125302
[TBL] [Abstract][Full Text] [Related]
10. Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients?
Alagözlü H; Gültekin F; Candan F
Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):204-8. PubMed ID: 11079258
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein subfraction composition in non-obese newly diagnosed non-insulin dependent diabetes after treatment with diet and glibenclamide.
Billingham MS; Milles JJ; Bailey CJ; Hall RA
Diabetes Res; 1989 May; 11(1):13-20. PubMed ID: 2515931
[TBL] [Abstract][Full Text] [Related]
12. Effect of nephropathy on the composition of apolipoprotein-containing particles in NIDDM.
Nagai T; Tomizawa T; Nakajima K; Uehara Y; Mori M
J Atheroscler Thromb; 1998; 5(2):54-9. PubMed ID: 10855558
[TBL] [Abstract][Full Text] [Related]
13. Effect of insulin-dependent diabetes on plasma lipoproteins in diabetic pregnancy.
Knopp RH; Van Allen MI; McNeely M; Walden CE; Plovie B; Shiota K; Brown Z
J Reprod Med; 1993 Sep; 38(9):703-10. PubMed ID: 8254593
[TBL] [Abstract][Full Text] [Related]
14. Apolipoproteins AI and B and plasma lipid values in well-treated diabetic patients from Romania.
Dabelea D; Serban V; Băcanu G; Deutsch G; Pataki C; Dan I
Rom J Intern Med; 1995; 33(3-4):249-56. PubMed ID: 8646198
[TBL] [Abstract][Full Text] [Related]
15. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
Kempen HJ; van Gent CM; Buytenhek R; Buis B
J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
[TBL] [Abstract][Full Text] [Related]
16. In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107-->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency.
Tilly-Kiesi M; Packard CJ; Kahri J; Ehnholm C; Shepherd J; Taskinen MR
Atherosclerosis; 1997 Feb; 128(2):213-22. PubMed ID: 9050778
[TBL] [Abstract][Full Text] [Related]
17. Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia.
Frénais R; Maugeais C; Ouguerram K; Zaïr Y; Bard JM; Charbonnel B; Magot T; Krempf M
Metabolism; 2001 Jun; 50(6):635-9. PubMed ID: 11398137
[TBL] [Abstract][Full Text] [Related]
18. Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.
Briones ER; Mao SJ; Palumbo PJ; O'Fallon WM; Chenoweth W; Kottke BA
Metabolism; 1984 Jan; 33(1):42-9. PubMed ID: 6419012
[TBL] [Abstract][Full Text] [Related]
19. Relationship between plasma lipid concentrations and HDL subclasses.
Yang Y; Yan B; Fu M; Xu Y; Tian Y
Clin Chim Acta; 2005 Apr; 354(1-2):49-58. PubMed ID: 15748599
[TBL] [Abstract][Full Text] [Related]
20. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance.
Pietzsch J; Julius U; Nitzsche S; Hanefeld M
Diabetes; 1998 Dec; 47(12):1928-34. PubMed ID: 9836526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
